论文部分内容阅读
目的:探讨甲氨蝶呤、米非司酮对异位妊娠的临床治疗效果。方法:对我院2012年2月~2013年1月收治的异位妊娠患者临床治疗病例进行抽样,将40例异位妊娠患者病例按照抽签法随机分为对照组与治疗组,每组20例。对照组采用甲氨蝶呤治疗,观察组在此基础上,联合米非司酮治疗。观察2组患者疗效与患者血β-HCG水平。结果:2组异位妊娠患者经过治疗之后,对照组治愈率为70.00%;治疗组治愈率为90.00%,治疗组患者血β-HCG下降程度也明显优于对照组。2组异位妊娠患者临床治疗效果具有显著差异性,具备统计学意义(P<0.05)。结论:异位妊娠患者采用甲氨蝶呤联合米非司酮治疗的临床疗效明显优于单一甲氨蝶呤治疗,治愈率极高,患者血β~HGG下降水平显著,值得进行临床推广应用。
Objective: To investigate the clinical effect of methotrexate and mifepristone on ectopic pregnancy. Methods: The clinical treatment of patients with ectopic pregnancy admitted to our hospital from February 2012 to January 2013 were sampled. The cases of ectopic pregnancy were randomly divided into control group and treatment group according to the lottery method. Twenty patients in each group . The control group methotrexate treatment, the observation group on this basis, combined with mifepristone treatment. The curative effect of two groups and the level of β-HCG in blood were observed. Results: After treatment, the cure rate of the control group was 70.00%. The cure rate of the treatment group was 90.00%. The decline of β-HCG in the treatment group was also better than that of the control group. There was significant difference in clinical treatment effect between two groups of patients with ectopic pregnancy, with statistical significance (P <0.05). Conclusion: The clinical efficacy of methotrexate combined with mifepristone in patients with ectopic pregnancy is significantly better than that of single methotrexate. The cure rate is extremely high. The level of β - HGG in blood of patients with ectopic pregnancy is significantly decreased, which is worthy of clinical application.